Helus Pharma Inc logo

Helus Pharma Inc

NEW
STU:R7E (Canada)   Ordinary Shares
€ 10 +0.080 (+0.81%) Sep 1
At Loss
P/B:
2.95
Market Cap:
€ 734.58M ($ 850.59M)
Enterprise V:
€ 687.36M ($ 795.90M)
Volume:
281.00
Avg Vol (2M):
1.88K
Trade In:
Volume:
281.00
At Loss

Helus Pharma Inc (STU:R7E) Dividend

Helus Pharma Inc (STU:R7E) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -115.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:R7E Dividend

Does Helus Pharma Inc (STU:R7E) pay a dividend?

Helus Pharma Inc (STU:R7E) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Helus Pharma Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Helus Pharma Inc has returned capital to shareholders via buybacks at a rate of -115.6% over the past 3 years.

What are dividend-paying alternatives to Helus Pharma Inc?

For dividend-paying alternatives in Helus Pharma Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.